Key result
Diabetes mellitus is linked to increased morbidity and long-term mortality in HFpEF.
Why the study?
Diabetes mellitus has a prevalence of approximately 45% in HFpEF, but the characteristics and outcomes of this population are poorly understood.
What is the impact of comorbid diabetes mellitus on morbidity and mortality in patients with HFpEF, and what are the underlying pathological mechanisms?
What is the impact of comorbid diabetes mellitus on morbidity and mortality in patients with HFpEF, and what are the underlying pathological mechanisms?
This review highlights that comorbid diabetes in HFpEF is highly prevalent (approximately 45%) and is associated with worse clinical outcomes, emphasizing the need for targeted, patient-centered treatments.
No takes yet. Share an insight, caveat, or question.
Comorbid diabetes signals higher HFpEF risk; leaves open whether targeted management improves outcomes.
McHugh et al. (2019) conducted a review in Heart failure with preserved ejection fraction (HFpEF) and diabetes mellitus. Diabetes mellitus was evaluated on Morbidity and long-term mortality. Diabetes mellitus is associated with increased morbidity and long-term mortality in patients with heart failure with preserved ejection fraction.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: